Gladius Capital Management LP Amgen Inc Transaction History

Gladius Capital Management LP

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	BUY	$262.75 - $319.31 $348,932 - $424,043	1,328 New	1,328 $414,000
Q2 2022 Aug 10, 2022	BUY	$230.71 - $256.74 $9,689 - $10,783	42 Added 17.87%	277 $68,000
Q1 2022 Apr 29, 2022	SELL	$219.27 - $242.57 $85,515 - $94,602	-390 Reduced 62.4%	235 $57,000
Q4 2021 Feb 08, 2022	BUY	$198.88 - $227.6 $36,395 - $41,650	183 Added 41.4%	625 $141,000
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $93,823 - $109,925	442 New	442 $94,000
Q2 2021 Aug 06, 2021	SELL	$233.58 - $259.14 $20,087 - $22,286	-86 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $1.62 Million - $1.89 Million	-7,311 Reduced 98.84%	86 $22,000
Q4 2020 Feb 09, 2021	BUY	$216.38 - $257.67 $1.41 Million - $1.68 Million	6,522 Added 745.37%	7,397 $1.7 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $205,318 - $228,331	875 New	875 $223,000
Q2 2020 Aug 07, 2020	SELL	$197.81 - $242.74 $195,831 - $240,312	-990 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$182.24 - $241.7 $180,417 - $239,283	990 New	990 $201,000
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $978,215 - $1.26 Million	-5,170 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $44,223 - $52,989	-254 Reduced 4.68%	5,170 $1 Million
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $1.97 Million - $2.31 Million	-11,844 Reduced 68.59%	5,424 $1.01 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $135,652 - $152,910	-750 Reduced 4.16%	17,268 $0
Q4 2018 Feb 15, 2019	BUY	$178.4 - $208.25 $3.21 Million - $3.75 Million	18,018 New	18,018 $3.51 Million

3,119

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $152B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Gladius Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Gladius Capital Management LP with notifications on news.